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Abstract
Oral microbiota consists of hundreds of different species of bacteria, fungi, protozoa and
archaea, important for oral health. Oral mycoses, mostly affecting mucosae, are mainly
caused by the opportunistic pathogen Candida albicans. They become relevant in denture-
wearers elderly people, in diabetic patients, and in immunocompromised individuals. Differ-
ently, bacteria are responsible for other pathologies, such as dental caries, gingivitis and
periodontitis, which affect even immune-competent individuals. An appropriate oral hygiene
can avoid (or at least ameliorate) such pathologies: the regular and correct use of tooth-
brush, toothpaste and mouthwash helps prevent oral infections. Interestingly, little or no
information is available on the effects (if any) of mouthwashes on the composition of oral
microbiota in healthy individuals. Therefore, by means of in vitro models, we assessed the
effects of alcohol-free commercial mouthwashes, with different composition (4 with chlor-
hexidine digluconate, 1 with fluoride, 1 with essential oils, 1 with cetylpyridinium chloride and
1 with triclosan), on several virulence traits of C. albicans, and a group of viridans strepto-
cocci, commonly colonizing the oral cavity. For the study here described, a reference strain
of C. albicans and of streptococci isolates from pharyngeal swabs were used. Chlorhexidine
digluconate- and cetylpyridinium chloride-containing mouthwashes were the most effective
in impairing C. albicans capacity to adhere to both abiotic and biotic surfaces, to elicit proin-
flammatory cytokine secretion by oral epithelial cells and to escape intracellular killing by
phagocytes. In addition, these same mouthwashes were effective in impairing biofilm forma-
tion by a group of viridans streptococci that, notoriously, cooperate with the cariogenic S.
mutans, facilitating the establishment of biofilm by the latter. Differently, these mouthwashes
were ineffective against other viridans streptococci that are natural competitors of S.
mutans. Finally, by an in vitro model of mixed biofilm, we showed that mouthwashes-treated
S. salivarius overall failed to impair C. albicans capacity to form a biofilm. In conclusion, the
results described here suggest that chlorhexidine- and cetylpyridinium-containing mouth-
washes may be effective in regulating microbial homeostasis of the oral cavity, by providing
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a positive balance for oral health. On the other side, chlorhexidine has several side effects
that must be considered when prescribing mouthwashes containing this molecule.
Introduction
Candida albicans is a commensal microorganism of humans: it dwells in the gastro-intestinal
tract, oral and vaginal mucosa of most healthy individuals. Sometimes, it behaves as an oppor-
tunistic pathogen, thus causing symptomatic mucosal infections.
C. albicans is characterized by several developmental cell types, including yeast and filamen-
tous forms (pseudohyphae and hyphae). Filaments are distinct from yeast-form cells in cell
wall structure, cell wall proteins, transcriptional programs and recognition/interaction with
immune system [1,2]. The ability of this species to switch between the yeast and the filamen-
tous forms is strongly associated with virulence. By ex vivo models of candidiasis [3–5], the
hyphal form of the fungus has been shown to cause more tissue damage than the yeast-form,
because it grants fungal ability to adhere to epithelial surfaces, form biofilm, elicit proinflam-
matory cytokines production and avoid phagocytosis and/or intracellular killing.
Among several mechanisms, cell surface hydrophobicity plays an important role in the
adhesion of C. albicans to inert surfaces. This adhesion capacity is one of the main predispos-
ing factors to oral infections, because abiotic materials such as acrylic denture base [6,7],
orthodontic metal braces [8] and surfaces of dental restorations [9] are often present inside the
oral cavity. Therefore, the ability of C. albicans to adhere to inert materials of this kind would
explain why Candida stomatitis and other fungal oral infections affect about 67% of elderly
denture wearers [6,7,9,10]. Not only is C. albicans able to bind to inert materials, but it can also
bind to biotic surfaces in the oral cavity (mucosal epithelia and teeth surface [11]) by means of
additional mechanisms, such as interactions between epithelial receptors and Candida adhe-
sins [12].
Epithelial cells produce a variety of cytokines in response to Candida infection, including
Granulocyte-Colony Stimulating Factor (G-CSF), Granulocyte Macrophage-Colony Stimulat-
ing Factor (GM-CSF), Interleukin-1α (IL-1α), Interleukin-1β (IL-1β) and Interleukin-6 (IL-6),
as well as the chemokines Regulated on Activation, Normal T Cell Expressed and Secreted
(RANTES), Interleukin-8 (IL-8) and Macrophage Inflammatory Protein 3α (MIP3α) [13,14].
Oral-pharyngeal candidiasis, mainly associated with C. albicans species, is common
amongst AIDS patients, where it is considered a marker of disease development in HIV posi-
tive individuals. Furthermore, oral-pharyngeal candidiasis is often associated with oral cancer,
it can develop in individuals that use dental prostheses (especially elderly people), and it fre-
quently affects diabetic patients, as well as terminally ill patients who fail to produce sufficient
saliva [15]. In several cases, oral candidiasis may be prevented by a good oral hygiene, includ-
ing the daily use of toothbrush and mouthwashes (MoWs). By means of an in vitro model, we
have recently demonstrated that both C. albicans hyphal development and biofilm formation/
persistence are affected by MoWs, provided that they contain chlorhexidine digluconate
(CHX) [16].
In addition to fungi, more than 700 species of bacteria have been identified and/or pre-
dicted to habit within the oral cavity [17]. Actually, bacteria are the main component of the
oral microbiota. Among them, many species belonging to the genus Streptococcus have been
described and their taxonomic relations have been unravelled by 16S rRNA gene sequence
comparisons. By such method, streptococci have been divided in 6 different groups: pyogenic,
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mitis, anginosus, mutans, salivarius, and bovis [18]. With the exception of the Streptococcus
mutans species (the main etiological agent of dental caries), oral streptococci are mainly con-
sidered avirulent or even beneficial organisms. In some cases, certain oral streptococci can
even hinder the development of a cariogenic S. mutans biofilm [19]. Recently, attention has
been focused on several components of the mitis group (S. gordonii, S. oralis, S. mitis, S. para-
sanguinis, S. sanguinis), which have been implicated in supporting a pathogenic multispecies
biofilm, given their ability to co-aggregate with other bacterial species and fungi as well. Not
only such co-aggregation has been shown to confer a mutual advantage in biofilm formation,
but also interactions among these microorganisms have been hypothesized to play a role dur-
ing both commensal colonization of oral surfaces and in the onset and development of oppor-
tunistic infections [20].
E. faecalis, which is another microbial component of the oral microbiota, is also important
for oral health, since it is one of the species mainly involved in failures of endodontic treat-
ments [21,22]. E. faecalis localizes in dentinal canaliculi of devitalized teeth, resists to common
disinfectants and endodontic irrigants [23,24], and can survive for long periods even under
starving conditions, until changes of root canal microenvironment will allow its re-growth
[25,26]. For bacteria, as well as for Candida, the biofilm production is an important virulence
trait, especially in an ecological setting like the oral cavity, where many microbial species share
the same ecological niche, compete for spaces and nutrients and therefore influence each
other. In particular, reciprocal interaction among different species of streptococci can be of
importance for the onset of oral diseases, such as carious lesions.
Not only some non-mutans streptococci, but also fungi may play a relevant role in the
onset of carious lesions. C. albicans, in particular, has been hypothesized to significantly con-
tribute to caries pathogenesis, especially in children, adolescents and young adults, because of
its acidogenicity, capability to form hyphae and to secrete dentine-degrading enzymes [27,28].
In addition, both in vitro [29] and in vivo [30,31] experimental evidence suggests that, within
the oral cavity, Candida-Streptococcal interactions do occur. Such interactions result in the
formation of multi-species biofilm communities, where microorganisms use quorum sensing
mechanisms to communicate with each other, to adjust their population density and to modu-
late gene expression patterns, in order to better adapt to the microenvironment where they
dwell [20].
Following the observations recently described [16], this study was aimed to expand our
knowledge about MoWs effects on several components of the oral microbiota. In particular,
by means of in vitro models, we investigated the behaviour of MoWs-treated C. albicans in
terms of: a) adhesion to both abiotic and biotic surfaces, b) capacity to elicit pro-inflammatory
response by epithelial cells and c) susceptibility to phagocytosis and intracellular killing, as
assessed by phagolysosome acidification. In parallel studies, we tested the capacity of these
same MoWs of impairing biofilm formation by several species of viridans streptococci and/or
by a mixed bacterial-fungal cell population.
Materials and methods
Candida albicans strains
The reference strain SC5314 (ATCC MYA-2876) of C. albicans was employed for the present
study. Fungal cultures were maintained by passages onto Sabouraud Dextrose Agar (SDA)
plates (OXOID, Milano, Italy) performed at least twice a week. Moreover, the previously
described [32] C. albicans CA1398, carrying the bioluminescence ACT1p-gLUC59 fusion
product (BLI C. albicans) was used. The latter was maintained by biweekly passages in Yeast
Peptone Dextrose Agar (YPD). The day before each experiment, fresh Candida cultures were
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seeded onto SDA or YPD plates and incubated at 37˚C. After overnight incubation, fungal
cells were harvested by a sterile inoculating loop, suspended in phosphate-buffered saline
(PBS, EuroClone, Whethereby, UK), washed twice by centrifugation at 3,500 rpm for 10 min-
utes, counted by Burker’s chamber and suspended at 1 x 106 yeast cells/ml in RPMI 1640
medium supplemented with 10% heat-inactivated fetal bovine serum (hiFBS) (Defined
Hyclone, Logan, UT, USA), gentamicin (50 mg/ml; Bio Whittaker, Verviers, Belgium),
Ciproxin (2 mg/ml; ICN) and L-glutamine (2 mM; EuroClone, Milan, Italy), from here indi-
cated as “cRPMI”. This fungal cell suspension, composed of yeast-like forms, was used
throughout the study to set up all the experiments.
For long-term storage, C. albicans was maintained as frozen stocks at -80˚C, in glycerol
solution 20% (v/v) (Incofar S.r.l., Modena, Italy).
TR146 oral epithelial cell line
The previously described human oral epithelial cell line TR146 [33] was maintained in Dulbec-
co’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12 (Sigma, St Louis, MO, USA) sup-
plemented with 15% hiFBS, gentamicin (50 mg/ml), Ciproxin (2 mg/ml) and L-glutamine (2
mM), hereafter referred to as “cF12”. For maintenance, medium was replaced thrice a week.
Cells were detached 8 days before the adhesion experiment by adding Trypsin/EDTA solution
(2 ml), incubating for 15 min at 37˚C with 5% CO2 and scraping to detach cells. Then fresh
cultures were started in cF12, at a concentration of 106/ml. TR146 cells were used for adhesion
assays, cytokines and chemokines determination and in mixed C. albicans/S. salivarius biofilm
production.
BV2 microglial cell line
The previously established murine microglial cell line BV2 [34] was maintained in cRPMI.
Cells were detached biweekly by vigorous shaking, and fresh cultures were started at a concen-
tration of 5 x 105/ml the day before each experiment.
BV2 cells were employed for the phagocytosis assay.
Bacterial strains
Bacteria were collected from pharyngeal swabs, seeded on COS plates (Biomerieux, Marcy-
L’Etoile, France) and allowed to grow for 24 hours at 35˚C. Alpha-haemolytic streptococci col-
onies were isolated and identification, at species level, was achieved by MALDI-TOF (Biomer-
ieux). The system allowed to identify isolates belonging to the species S. salivarius, S. sanguinis,
S. parasanguinis, S. vestibularis, and Enterococcus faecalis, but it could not discriminate
between the species S. mitis and S. oralis; therefore, the 3 isolates used in the present study
were indicated as S. mitis/oralis. Seventeen isolates were employed: 3 isolates each of the spe-
cies S. salivarius, S. mitis/oralis, S. sanguinis, S. parasanguinis and E. faecalis and 2 isolates of
the species S. vestibularis.
For long-term storage, bacteria were maintained as frozen stocks at -80˚C, in Tryptic Soy
Broth (TSB, Difco Laboratories, Detroit, MI, USA) with glycerol 5% (v/v).
The day before each experiment, 0.2 ml of bacteria from frozen stocks were seeded in 4 ml
of TSB and incubated at 37˚C. After overnight incubation, 0.1 ml of bacterial suspensions were
placed in 96-well plates and counted by measuring optical density (OD) at 595 nm wavelength,
by means of a plate reader (Tecan Sunrise, Austria). The bacterial concentration was calculated
by interpolating OD values to a McFarland standard curve [35]. Bacteria were then centrifuged
and suspended in Brain Heart Infusion (BHI) broth (Liofilchem S.r.l., Italy) to a concentration
of 1.5 x 108 CFU/ml.
Effects of mouthwashes on oral microbiota
PLOS ONE | https://doi.org/10.1371/journal.pone.0207262 November 15, 2018 4 / 20
Mouthwashes
Six commercial Mouthwashes (MoWs), operationally indicated with Arabic numbers, were
employed. These mouthwashes are the same already employed in a previous study conducted
by our group [16]. MoW 1 (CURASEPT 0.20, Curadent Healthcare S.p.A., Saronno (VA),
Italy), MoW 2 (DENTOSAN COLLUTORIO, Recordati S.p.A., Milano, Italy) and MoW 3
(MERIDOL COLLUTORIO, Gaba-Colgate-Palmolive, Świdnica, Poland) contained 0.2%
chlorhexidine digluconate (CHX). MoW 7 (PARODONTAX, GlaxoSmithKline, Brentford,
UK) contained 0.06% CHX and 250 ppm F- sodium fluoride. MoW 4 (ELMEX SENSITIVE
PROFESSIONAL, Gaba, Therwil, Switzerland) and MoW 5 (LISTERINE TOTAL CARE
ZERO, Johnson&Johnson, Maidenhead, UK) included in their formulation fluorine-contain-
ing molecules and essential oils respectively. Two additional commercial mouthwashes, with
different formulations, were employed in focused experiments: MoW 8 (ORAL B, Procter &
Gamble, U.K.), containing 0.05% cetylpyridinium chloride (CPC) and 0.05% sodium fluoride
and MoW 9 (PlaKKontrol Protezione Totale, IDECO, Bolzano, Italy), containing Triclosan
and sodium fluoride. Details on MoWs composition are available in S1 Table.
All the MoWs selected for the present study were ethanol-free.
Operationally, the contact times of 5 and 15 minutes between Candida and the different
MoWs have been chosen in order to mimic the everyday life employment of MoWs. Indeed,
manufacturers recommend to avoid eating and drinking for at least 30 minutes after rinsing
with MoWs, since the active molecules bind to the teeth and mucosal surfaces and are released
gradually over time. Such property, known as substantivity, has been demonstrated for CHX, a
molecule widely employed in MoWs formulations. This molecule, besides its direct antibacte-
rial and antifungal action, can bind to surrounding tissues and then be released slowly, over
extended periods of time [10,36]. Our previous study has shown that at the Candida:MoW 1:2
dilution (i.e., the same employed for the present study) there are no differences on biofilm for-
mation and Candida metabolic activity between 1 and 5 minutes contact time with the MoWs;
similarly, no differences have been observed between 15 and 30 minutes contact time [16,18].
Therefore, the 5 minutes contact time has been chosen to describe the immediate MoWs effect
on Candida, whereas the 15 minutes contact time has been chosen to provide information on
MoWs substantivity.
In vitro adhesion assays
Adhesion of Candida yeast cells was assessed both on abiotic surfaces and to oral epithelial
cells.
Adhesion to abiotic surfaces: BLI C. albicans cells were harvested by a sterile inoculating
loop, suspended in PBS, washed twice by centrifugation at 3,500 rpm for 10 minutes, counted
by Burker’s chamber and suspended at 2 x 106 yeast cells/ml in PBS. Then, 0.5 ml of Candida
suspension were added to Eppendorf tubes containing 0.5 ml of PBS or 0.5 ml of the different
MoWs, and incubated at 37˚C with 5% CO2 for 5 or 15 minutes. MoWs were then removed by
spinning twice all the tubes at 4,500 rpm for 8 minutes, and by replacing the supernatants
every time with PBS. After the last wash, each pellet was suspended in cF12 in order to have a
final concentration of 1 x 106 fungal cells/ml. One hundred microliters of these fungal suspen-
sions were added (each condition in triplicate) to black 96-well microtiter plates with a trans-
parent bottom (Perkin Elmer Life Sciences) and incubated for 1 hour at 37˚C. Then, each well
was gently washed (3 times with 200 μl of PBS) to remove the non-adhered fungal cells. Finally,
according to a previously described procedure [32], 2 μM coelenterazine (SynChem, Ohm,
Germany) in luciferase assay buffer (LA buffer) were added to each well; the bioluminescence
was read immediately with a luminometer (Victor X Light, Perkin Elmer Life Sciences) and
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the signal was expressed as relative luminescence units (RLU). According to the data by Enjal-
bert and coworkers [32], bioluminescence sensitivity corresponds to 1,000 gLUC59-expressing
C. albicans cells. After reading, the adhered fungal cells were also evaluated by colony forming
units counts (CFU). As detailed elsewhere [37], the LA buffer was removed from each well,
100 μl of Trypsin/EDTA solution were added to each well, then plates were incubated for 15
min at 37˚C plus 5% CO2 to detach cells. Hence, fungal suspensions were seeded onto SDA
plates, which were placed at 37˚C for 24 hours. The CFU were then evaluated.
Adhesion to oral epithelial cells: Two-hundred microliters of TR146 human epithelial cells
(1 x 105 cells/ml) were seeded into black 96-well microtiter plates with a transparent bottom
(Perkin Elmer Life Sciences). The plate was incubated for 3 days at 37˚C in order to allow the
formation of a monolayer of epithelial cells homogeneously distributed on the bottom of each
well. After 3 days, the BLI C. albicans cells were harvested and the experiment was carried out as
detailed above. After reading, the adhered fungal cells were evaluated also by colony forming
units counts (CFU), by the same procedure described above for the adhesion to abiotic surfaces.
Candida viability/growth assay
BLI C. albicans cells (4 x 105/ml) were pre-treated with MoWs or with PBS for 5 and 15 min-
utes. Then, fungal suspensions were washed twice with PBS to remove MoWs and suspended
in 1 ml of PBS. Then, 100 μl of each fungal suspension were seeded onto SDA plates. CFU
counts were evaluated after 24 hours of incubation at 37˚C.
Cytokines and chemokines
Two-hundred microliters of TR146 human epithelial cells (1 x 105 cells/ml) were seeded into
96-well microtiter plates (Costar 3595, Corning, NY, USA) and incubated for 3 days at 37˚C in
order to allow the formation of a homogeneously distributed monolayer of epithelial cells on
the bottom of each well. After 3 days, 0.5 ml of Candida suspension (2 x 106 yeast cells/ml in
PBS) were added to Eppendorf tubes containing 0.5 ml of PBS or 0.5 ml of the different
MoWs, and incubated at 37˚C with 5% CO2 for 5 or 15 minutes. MoWs were then removed by
spinning twice all the tubes at 4,500 rpm for 8 minutes, and by replacing the supernatants
every time with PBS. After the last wash, each pellet was suspended in cF12 in order to have a
final concentration of 1 x 106 fungal cells/ml. One hundred microliters of these suspensions
were added to the TR146-containing wells of the 96-well microtiter plate and incubated for 24
hours at 37˚C. As positive control, TR-146 cells were stimulated with 1 μg/ml of LPS. As nega-
tive controls, wells containing TR-146 cells, which did not undergo infection with Candida or
stimulation with LPS, were included. Each condition was tested in triplicate. Then, superna-
tants were collected and cytokines/chemokines levels were assessed by means of Quantibody
Human Inflammation Array 1 (Ray Biotech Inc., Norcross, GA, USA), an antibody microarray
system already employed for cytokines/chemokines determinations in several biological fluids
[38,39]. With this array the following cytokines/chemokines could be quantitatively detected:
IL-1α, IL-1β, Interleukin-4 (IL-4), IL-6, IL-8, Interleukin-10 (IL-10), Interleukin-13 (IL-13),
Monocyte Chemoattractant Protein-1 (MCP-1), Interferon-γ (IFN-γ), Tumor Necrosis Fac-
tor-α (TNF-α). The supernatants were used undiluted and the assay was conducted according
to the Manufacturer’s instructions. The fluorescent signal from the slides was read by using a
ScanArray Gx scanner (Perkin-Elmer, Cambridge, UK). Images generated were saved as TIFF
files and quantified with the ScanArrayExpress software, provided by Perkin-Elmer. Since no
specific indications on cut-offs were provided, all the cytokine/chemokine levels which, inter-
polated to their respective calibration curves, resulted below 0 pg/ml, were considered as
negative.
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In vitro phagocytosis assay
C. albicans SC5314 cells were harvested by a sterile inoculating loop, suspended in PBS,
washed twice by centrifugation at 3,500 rpm for 10 minutes, counted by Burker’s chamber and
resuspended at 2 x 106 yeast cells/ml in PBS. Then, 0.5 ml of Candida suspension were added
to Eppendorf tubes containing 0.5 ml of PBS or 0.5 ml of the different MoWs, and then incu-
bated at 37˚C with 5% CO2 for 5 or 15 minutes. MoWs were then removed by spinning all the
tubes twice at 4,500 rpm for 8 minutes, and by replacing the supernatant every time with PBS.
After the last wash, each pellet was suspended in 100 μl of FITC fluorescent dye (Sigma), previ-
ously diluted 1:10 with PBS, and incubated for 20 minutes. FITC was then removed by spin-
ning all the tubes three times at 4,500 rpm for 8 minutes and by replacing the supernatant
every time with PBS. After the last washing, each pellet was suspended in 240 μl of cRPMI in
order to have working strength suspensions of 4 x 106 fungal cells/ml.
In the meantime, BV2 cells were seeded into Lab-Tek II chamber slides wells (Nalge Nunc
International, Naperville, IL, USA). In order to strengthen adhesion of BV2 cells to the glass
bottom of the wells, the latter were pretreated with poly-L-lysine (Sigma-Aldrich; 10 μg/well),
for 30 minutes, and washed twice with PBS. BV2 cells (2 x 106 cells/ml, 100 μl/well) were then
seeded and incubated for 30 minutes at 37˚C with 5% CO2. BV2 cells were thus infected by
adding 100 μl of Candida suspension, the effector-target (E:T) ratio being 1:2. Then, 10 μl/well
of LysoTracker Red DND-99 fluorescent dye (Molecular Probes, Life Technologies, Eugene,
Oregon, USA), at 5 mM working strength concentration, were added. The chamber slides
were then incubated for 1.5 hours at 37˚C with 5% CO2. Thirty minutes before the end of incu-
bation, an additional volume of 10 μl of LysoTracker Red DND-99 fluorescent dye were added
to each well. Fifteen minutes before the end of incubation, 40 μl of Uvitex 2B fluorescent dye
(Polysciences, Inc, PA, USA) were added to each well of the chamber slide.
At the end of the incubation, all the wells were washed twice with warm cRPMI (5 minutes
each) and fixed for 30 minutes with 4% paraformaldehyde (PFA) (Sigma-Aldrich) in PBS at
+4˚C, protected from light. PFA was then removed by means of a double wash with cold PBS
(10 minutes each). The chamber slide was then unset, by removing the plastic walls of the wells
and the slide surface was treated with ProLong Gold Antifade Reagent (Molecular Probes,
Invitrogen, St. Louis, Mo, USA) in order to suppress the photobleaching effect and to preserve
the signals of fluorescently labeled target molecules. The fluorescence of phagocytosed and
non-phagocytosed fungi was visualized by means of epifluorescence microscopy Nikon
Eclypse 90i (Nikon Instruments, Tokyo, Japan) equipped with different filters for reading dif-
ferent fluorescent signals. For clarity, FITC fluorescent dye stained in green all Candida cells
and its signal was read by FITC filter. LysoTracker Red DND-99 fluorescent dye stained in red
the Candida cells inside acidic phagolysosomes and its signal was read by TRITC filter. Uvitex
2B fluorescent dye stained in blue all the Candida cells that had not been phagocytosed and its
signal was read by DAPI filter. The phagocytosis percentage was then calculated by counting
the cells containing one or more Candida on a total of 200 phagocytic cells scored. The phago-
cytosis index was calculated by counting the total number of phagocytosed Candida (including
those inside acidic phagolysosomes) on a total of at least 200 Candida-containing phagocytic
cells. The acidic phagolysosomes percentage was calculated on a total of at least 200 Candida-
containing phagocytic cells by counting Candida cells inside acidic phagolysosomes on the
total number of phagocytosed Candida cells.
Biofilm production by oral streptococci and E. faecalis
Bacterial biofilm production was assessed for each individual Streptococcus isolate. Biofilm was
allowed to form on flat-bottom 96-well plates (Corning Incorporated, NY, USA), according to
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the protocol described by Stepanović and coworkers, with minor modifications [40]. Briefly,
1.8 ml of bacteria cell suspensions (1.2 x 107 CFU/ml) in BHI broth were added to 1.8 ml of
each MoW or PBS and incubated at 37˚C for 1 minute. Then, MoWs were removed by spin-
ning at 4,500 rpm for 8 minutes and by suspending the pellets in PBS. After the last washing
step, pellets were suspended in BHI broth to a working strength concentration of 1.5 x 107
CFU/ml, seeded in the wells of a 96-well plate (each condition in triplicate) and incubated at
37˚C with 5% CO2 for 48 hours. Finally, to measure biofilm formation, Crystal Violet (CV)
assay was performed. The OD was read at 570 nm wavelength, by means of a plate reader
(Tecan Sunrise, Austria). The capacity to form BF of MoWs-treated bacteria was expressed as
OD percentage, as compared to the OD of the PBS-treated counterpart, which was considered
as 100%.
C. albicans biofilm production upon co-culture with MoWs-treated S.
salivarius
An isolate belonging to the species S. salivarius (considered a “pro-cariogenic” species) was
selected to study the influence (if any) of MoWs-pretreated streptococci on the capacity to
form biofilm by C. albicans. This particular isolate was chosen because of its susceptibility to
most of the MoWs employed (see below).
Two-hundred microliters of TR146 human epithelial cells (1 x 105 cells/ml) were seeded
into black 96-well microtiter plates and incubated for 3 days at 37˚C, in order to allow the for-
mation of a monolayer of epithelial cells homogeneously distributed on the bottom of each
well. After 3 days, 600 microliters of S. salivarius isolate 12 cell suspensions (1.5 x 107 CFU/ml)
in BHI broth were added to 600 μl of each MoW or PBS and incubated at 37˚C for 1 minute.
Then, MoWs were removed by spinning at 4,500 rpm for 8 minutes and by suspending the
pellets in PBS. After the last washing step, pellets were suspended in cF12 medium, seeded
(each condition in triplicate) together with BLI C. albicans (1 x 106/ml, 100 μl/well) in the
TR146-containing wells of the 96-well plate described above and incubated at 37˚C with 5%
CO2 for 24 hours. After removal of the suspensions containing the non-adhered fungal cells,
the wells were washed 3 times with 200 μl of PBS. Finally, 2 μM coelenterazine in LA buffer
was added to each well and the bioluminescent signal was read immediately with a lumin-
ometer (Victor X Light, Perkin Elmer Life Sciences). After reading, the supernatants from
each well were thrown, substituted with the same volume of fresh cF12 medium and incubated
for further 24 hours. After this time, all the wells were washed 3 times (as described above),
2 μM coelenterazione in LA buffer was added to each well and the bioluminescent signal was
read immediately with the luminometer.
Statistical analysis
All the data contained in the graphs are expressed as average values ± standard errors of at
least 3 independent experiments. Analysis of variance (ANOVA) and Bonferroni post-hoc test
were carried out by IBM SPSS Statistics 23 to assess overall differences amongst MoWs-treated
groups in relation to control groups. Statistical significance was set at p<0.05.
Results
Adhesion of MoWs-treated C. albicans to abiotic surface and epithelial cells
In order to evaluate the effects of the MoWs on C. albicans capacity to adhere to abiotic (plas-
tic) and biotic (TR146 epithelial cells) surfaces, BLI C. albicans was employed. In particular,
fungal cells treated either with MoWs or PBS (for 5 or 15 minutes) were seeded into a 96-well
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plate and were allowed to adhere for 1 hour at 37˚C, before washing and bioluminescence
measurement. As expected, Candida cells treated with PBS returned the highest biolumines-
cent signals, indicating the capacity of the fungus per se to adhere to the plastic of the micro-
wells. When Candida was treated with MoWs 1, 2, 3, 5, 7 and 8, little or no bioluminescent
signals were detectable, indicating a failure of the fungus to adhere to the plastic. These results
were consistent, irrespective of the MoWs incubation times; statistical analysis showed that
bioluminescent readings from the wells containing MoWs-treated Candida were significantly
lower than readings from PBS-treated Candida, used as negative control. MoW 4- and MoW
9-treated Candida returned a bioluminescent signal higher than those from the other MoWs.
Yet, after 15 minutes of incubation such signal was significantly lower than that recorded from
PBS-treated Candida, indicating that, tough less effective than the others, MoWs 4 and 9 were
still capable to significantly impair Candida adhesion to the wells (Fig 1A).
Adhesion of MoWs-treated C. albicans to TR146 cells was significantly lower than that of
PBS-treated Candida, for all but MoWs 4 and 9. Candida cells treated with MoWs 1, 2, 3, 5, 7
and 8 returned little or no bioluminescent signals, indicating an almost complete failure of the
fungus to adhere to the oral epithelial cells, after MoWs treatment. On the contrary, MoW 4-
and MoW 9-treated Candida returned a bioluminescent signal, comparable to that collected
from PBS-treated Candida, indicating that adhesion to the epithelial cells remained substan-
tially not affected by these MoWs (Fig 1B). CFU counts of adhered fungal cells confirmed the
bioluminescence results: > 300 CFU/ml for PBS-, MoW 4- and MoW 9-treated Candida
and< 30 CFU/ml for MoW 1-, MoW 2-, MoW 3-, MoW 5-, MoW 7- and Mow 8- treated
Candida, after 15 min both on abiotic and biotic surfaces.
In order to verify if adhesion impairment by MoWs was due also to a decrease in fungal
cells viability, we evaluated the CFU counts of fungal cells pre-incubated for 5 or 15 minutes
with MoWs. Our results showed that growth of Candida pre-treated with MoWs 2, 3, 5, 7 and
8 (irrespective of the contact times) was almost completely inhibited (< 30 CFU). Differently,
Fig 1. Adhesion of MoWs-treated BLI C. albicans to plastic and epithelial cells. Yeast cells, treated for 5 minutes (black columns) or 15
minutes (grey columns) with MoWs or PBS (as a control), were washed, suspended in cF12 and seeded (1 x 105 cells/well) in 96-well plates
where they were let adhere for 1 hour at 37˚C. Then, the adhesion to abiotic surfaces (plastic bottom of the well plates—A) and adhesion to
biotic surfaces (TR146-covered bottom of the well plates—B) were assessed by bioluminescence. Signals collected are expressed as relative
luminescence units (RLU). The results are mean values ± standard errors of triplicates. #p< 0.05 or ��p< 0.001 indicate significant differences
between MoWs-treated vs PBS-treated BLI C. albicans. MoW1: Curasept 0.20; MoW2: Dentosan Collutorio; MoW3: Meridol Collutorio;
MoW4: Elmex Sensitive Professional; MoW5: Listerine Total Care Zero; MoW7: Parodontax; MoW8: Oral B; MoW9: PlaKKontrol Protezione
Totale.
https://doi.org/10.1371/journal.pone.0207262.g001
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from undiluted supernatants of MoW 4- and PBS-treated Candida, more than 300 CFU could
be counted, regardless of the contact times. From fungal suspensions pre-treated with MoW 1
and MoW 9, 115 ± 5.6 and 112 ± 4.2 and 245 ± 7.4 and 230 ± 2.5 CFU respectively could be
counted after 5 or 15 minutes contact time.
Cytokines and chemokines secretion by TR146 oral epithelial cells
incubated with MoWs-treated C. albicans
C. albicans, pretreated with MoWs or PBS, was used to infect monolayers of TR146 oral epi-
thelial cells; 24 h later, the capacity of Candida to induce a secretory response was evaluated.
By using an antibody microarray assay, the supernatants were screened for levels of IL-1α, IL-
1β, IL-4, IL-6, IL-8, IL-10, IL-13, MCP-1, IFN- γ and TNF-α. Candida cells treated with PBS
were capable to induce the secretion of both IL-1α and IL-1β (but not of the other cytokines
and chemokines) by TR146 oral epithelial cells. When TR146 cells were infected with MoWs-
pretreated Candida, a significant reduction in the secretion of both IL-1α (Fig 2A) and IL-1β
(Fig 2B) was observed with respect to controls, namely TR146 cells infected with PBS-pre-
treated Candida. The most pronounced reduction was observed upon Candida pretreatment
with MoWs 1, 2, 3, 5 and 7, irrespective of the 5 or 15 minutes contact time. Also, Candida pre-
treatment with MoW 4 significantly impaired fungal capacity to elicit IL-1α and IL-1β, but to
a lesser extent (Fig 2A and 2B). None of the other cytokines/chemokines assessed by protein
array were detectable at appreciable levels in the same culture supernatants. As expected, LPS
stimulation induced secretion of IL-1α, IL-1β and TNF-α. The values of pg/ml obtained after
LPS stimulation, were 1004.7 pg/ml ± 35.8 for IL-1α and 53 pg/ml ± 5.2 for IL-1β.
Susceptibility to phagocytosis of MoWs-treated C. albicans
Susceptibility to phagocytosis of MoWs-treated Candida cells was assessed by means of an in
vitro assay, which uses a previously established murine microglial cell line BV2, known to effi-
ciently ingest and intracellularly kill Candida [41]. Thus, PBS- or MoWs-pretreated C. albicans
Fig 2. Induction of proinflammatory cytokines secretion by TR146 cells infected with MoWs-treated C. albicans. Yeast cells, treated for 5
minutes (black columns) or 15 minutes (grey columns) with MoWs or PBS (as negative control), were washed, suspended in cF12 and seeded (1
x 105 cells/well) in 96-well plates containing a 3 days old monolayer of TR146 cells. After 24 hours incubation at 37˚C, supernatants were
collected and cytokines/chemokines levels were assessed by an antibody microarray. Levels of IL-1α (A) and IL-1β (B) are shown. The results
are mean values ± standard errors of triplicates. ��p< 0.001 indicate significant differences between MoWs-treated vs PBS-treated Candida.
MoW1: Curasept 0.20; MoW2: Dentosan Collutorio; MoW3: Meridol Collutorio; MoW4: Elmex Sensitive Professional; MoW5: Listerine Total
Care Zero; MoW7: Parodontax.
https://doi.org/10.1371/journal.pone.0207262.g002
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cells (5 or 15 minutes) were exposed to BV2 cells for 1.5 hours; then, phagocytosis percentage,
phagocytosis index and acidic phagolysosomes percentage were calculated. By ANOVA test,
the differences in phagocytosis percentage amongst the MoWs-treated samples and the PBS-
treated controls never reached the level of significance (always p>0.05), irrespective of the
contact time (Fig 3A).
Similarly, the differences in phagocytosis index amongst the MoWs treated samples and the
PBS-treated controls never reached the level of significance (always p>0.05) (Fig 3B). Differ-
ently, when the acidic phagolysosomes percentage was assessed, two trends were detected. Spe-
cifically, Candida cells treated with MoWs 1 and 4 returned acidic phagolysosomes
percentages not statistically different from those of the PBS-pretreated Candida, as assessed by
ANOVA test (p>0.05). On the contrary, Candida cells treated with MoWs 2, 3, 5 and 7
returned an acidic phagolysosome percentage much higher than the controls’. By ANOVA
test, such values were significantly higher than those of the control samples (p<0.05). Such
results were independent from the 5 or 15 minutes contact times (Fig 3C).
Morphological analysis by microphotographs revealed that Candida cells, exposed to MoW
1, MoW 4 or PBS could develop hyphae, (Fig 4A) and, as shown by the TRITC filter which
reads the red fluorescence of the Lyso-Tracker dye, only a few red spots were detectable (Fig
4B–white arrows). On the contrary, in samples treated with MoWs 2, 3, 5 and 7, no hyphal
forms were observed (Fig 4C) and, as assessed by TRITC filter, red spots were abundantly
observed (Fig 4D).
Effects of MoWs on biofilm production by streptococci and E. faecalis
The effects (if any) of the MoWs on the capacity of oral streptococci to produce biofilm were
investigated. Isolates from 5 species of oral streptococci and Enterococcus faecalis were treated
for 1 minute with the same MoWs used for Candida and then allowed to form a biofilm. Biofilm
formation was assessed after 48 hours incubation. Control groups, treated for 1 minute with
PBS, showed that all the isolates were capable to produce biofilm, under the experimental condi-
tions detailed in Material and Methods. However, when pre-treated with the MoWs, differences
in the capacity to form biofilm could be observed, amongst species and according to the MoWs
employed. Specifically, for S. parasanguinis, E. faecalis, S. vestibularis and S. salivarius the
Fig 3. Effects of the different MoWs on C. albicans susceptibility to phagocytic cells. Yeast cells, treated for 5 minutes (black columns) or 15
minutes (grey columns) with MoWs or PBS, as a control, were washed, suspended in cRPMI, fluorescently labelled and seeded (2 x 105 cells/
well) in chamber-slides containing BV2 phagocytic cells (1 x 105 cells/well; E:T ratio = 1:2). After 1.5 hours incubation at 37˚C, slides were fixed
and fluorescent signal was acquired. The following parameters were then calculated: phagocytosis percentage (A), phagocytosis index (B) and
acidic phagolysosomes percentage (C). The results are mean values ± standard errors of at least triplicate samples. ##p< 0.001 indicate
significant differences between MoWs-treated vs PBS-treated Candida. MoW1: Curasept 0.20; MoW2: Dentosan Collutorio; MoW3: Meridol
Collutorio; MoW4: Elmex Sensitive Professional; MoW5: Listerine Total Care Zero; MoW7: Parodontax.
https://doi.org/10.1371/journal.pone.0207262.g003
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Fig 4. Morphology of C. albicans treated with the different MoWs and then exposed to phagocytic cells. Representative fluorescent
microscopy images of yeast cells, treated for 5 or 15 minutes with MoWs or PBS, as a control, washed, suspended in cRPMI, fluorescently
labelled and seeded (2 x 105 cells/well) in chamber-slides containing BV2 phagocytic cells (1 x 105 cells/well; E:T ratio = 1:2). After 1.5 hours
incubation at 37˚C, slides were fixed and fluorescent signal was acquired. C. albicans cells treated with PBS, MoW 1 or MoW 4 retain their
ability to undergo dimorphic transition, even when phagocytized by macrophages (representative image in panel A of MoW 4 –black arrows),
therefore, only little numbers of red spots (representative image in panel B of MoW 4—white arrows) are visible. C. albicans cells treated with
MoWs 2, 3, 5 and 7, are inhibited in their capacity to undergo dimorphic transition and they retain their yeast morphology (representative
image in panel C of MoW 2), therefore most of them are localized inside acidic phagolysosomes (representative image in panel D of MoW 2)
where they are likely inactivated. The different colours displayed by fungal cells in panels A and C indicate the fungi simply phagocytized (green
Candida, stained with FITC), the fungi phagocytized and associated with acidic phagolysosomes (red Candida, stained with the acidotropic
LysoTracker DND-99 dye), or the fungi not phagocytized by BV2 cells (blue Candida, stained with Uvitex 2B). Panels B and D show the same
images of panels A and C respectively, using the TRITC filter, which highlights only the Candida cells (stained in red with LysoTracker DND-99
dye) localized within the acidic phagolysosomes. Every condition was assessed in at least 3 different experiments. MoW1: Curasept 0.20; MoW2:
Dentosan Collutorio; MoW3: Meridol Collutorio; MoW4: Elmex Sensitive Professional; MoW5: Listerine Total Care Zero; MoW7: Parodontax.
https://doi.org/10.1371/journal.pone.0207262.g004
Effects of mouthwashes on oral microbiota
PLOS ONE | https://doi.org/10.1371/journal.pone.0207262 November 15, 2018 12 / 20
biofilm production was significantly reduced (even though with slight differences amongst iso-
lates) by the treatment with all the MoWs, but MoW 4. The bacteria incubated with MoW 4
were able to produce a biofilm mass very similar to the controls (Fig 5A to 5D).
Differently, the S. mitis/oralis and S. sanguinis isolates were poorly affected by the treatment
with any of the MoWs, with the exception of S. mitis/oralis isolate 34 (that was inhibited by
MoWs 2, 3 and 7) and S. sanguinis isolate 10 (that was inhibited by MoWs 1, 2, 3 and 5) (Fig
5E and 5F).
Moreover, being S. salivarius isolate 12 particularly susceptible to most of the MoWs, it was
chosen to test CPC-containing MoW 8 and triclosan-containing MoW 9. We found that the
two MoWs had opposite effects on biofilm formation. As shown in Fig 5, panel D, MoW 8
completely inhibited biofilm formation, whereas the contact with MoW 9 did not have any
effect.
Effects of MoWs on mixed biofilm
As detailed above, amongst the investigated streptococci, S. salivarius isolates were the most
affected by MoWs treatment. Therefore, in order to assess if the MoWs-mediated impairment
of S. salivarius biofilm formation could affect also C. albicans biofilm formation, S. salivarius
isolate 12 was treated with the different MoWs or PBS for 1 minute and then added, together
Fig 5. Effects of MoWs on viridans streptococci and E. faecalis biofilm production. Bacterial isolates, belonging to the species S.
parasanguinis (A), E. faecalis (B), S. vestibularis (C), S. salivarius (D), S. mitis/oralis (E) and S. sanguinis (F) were treated for 1 minute with PBS
or with MoWs, before being washed, suspended in BHI broth, seeded (1.5 x 107 CFU/ml) in 96-well plates and incubated at 37˚C for 48h to
allow biofilm formation. Biofilm biomass was then assessed by CV assay and the results were expressed as percentage of biofilm production with
respect to the 100% biofilm of PBS-treated bacteria. Each result is the mean value ± standard error of triplicate samples. �p< 0.05 or ��p< 0.001
indicate significant differences between MoWs-treated vs PBS-treated bacteria. MoW1: Curasept 0.20; MoW2: Dentosan Collutorio; MoW3:
Meridol Collutorio; MoW4: Elmex Sensitive Professional; MoW5: Listerine Total Care Zero; MoW7: Parodontax; MoW8: Oral B; MoW9:
PlaKKontrol Protezione Totale.
https://doi.org/10.1371/journal.pone.0207262.g005
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with untreated bioluminescent C. albicans, to wells containing 3 day old monolayers of TR146
oral epithelial cells. Plates were then incubated at 37˚C and the BLI C. albicans biofilm forma-
tion was assessed, by bioluminescence, after 24h (early biofilm) and 48 hours (mature biofilm).
The results, after 24 hours incubation, showed that the treatment of S. salivarius with MoWs 1
and 5 significantly (p<0.05) impaired C. albicans biofilm formation at early stages, with
respect to Candida incubated with PBS-pretreated S. salivarius. Differently, no effects on C.
albicans early biofilm were observed when S. salivarius had been pretreated with the other
MoWs or with PBS. Bioluminescence measurement after 48 hours showed no effects on C.
albicans biofilm production, irrespective of the fact that S. salivarius had or had not been pre-
treated with any of the MoWs (Fig 6).
Discussion
In a recent study [16], we have shown that several commercial MoWs exert anti-Candida
activity. The observed differences in yeast cell growth, hyphal formation and biofilm produc-
tion and persistence have been shown to depend on the MoWs composition and the fungal
morphological/functional status. Here, we expand such results by investigating the effects of
Fig 6. Effect of MoWs-pretreated S. salivarius on C. albicans capacity to form biofilm. S. salivarius isolate 12 was
treated for 1 minute with PBS or with MoWs, before being washed, suspended in cF12 and seeded (1.5 x 107 CFU/ml)
together with untreated C. albicans cells (2 x 106/ml) onto a TR146 epithelial cells monolayer. The plates were then
incubated at 37˚C and BLI C. albicans biofilm biomass was then assessed by bioluminescence at 24 hours (black
columns) and 48 hours (grey columns). Each result is the mean value ± standard error of triplicate samples. �p< 0.05
indicate significant differences between MoWs-treated vs PBS-treated bacteria. MoW1: Curasept 0.20; MoW2:
Dentosan Collutorio; MoW3: Meridol Collutorio; MoW4: Elmex Sensitive Professional; MoW5: Listerine Total Care
Zero; MoW7: Parodontax; MoW8: Oral B; MoW9: PlaKKontrol Protezione Totale.
https://doi.org/10.1371/journal.pone.0207262.g006
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the same commercial MoWs on other Candida virulence factors, such as adhesion to abiotic
and biotic surfaces, capacity to elicit pro-inflammatory responses by epithelial cells and suscep-
tibility to phagocytosis and intracellular killing.
C. albicans capacity to adhere to both abiotic and biotic surfaces is the first stage of fungal
invasion [9] and biofilm formation [42]. Here, we show that the treatment with the MoWs sig-
nificantly impairs Candida capacity to adhere to plastic, irrespective of the contact times. Such
impairment has been observed with all the MoWs, even though to a lesser extent when using
MoWs 4 and 9. Therefore, the MoWs employed in the present study may help prevent oral
fungal infections via the impairment of C. albicans adhesion to abiotic surfaces, frequently
present in several types of patients. In addition, MoWs 1, 2, 3, 5, 7 and 8 have shown to impair
Candida adhesion also to oral epithelial cells. Interestingly, MoWs 4 and 9 only impair (with-
out blocking completely) Candida adhesion to plastic, leaving the fungus the ability to adhere
to oral epithelial cells. These data suggest that such two MoWs are likely effective only in
reducing non-specific forces, such as cell surface hydrophobicity [6–10], while the binding
between fungal adhesins and epithelial receptors remains unaffected. Noteworthy, the
observed impairment of adhesion mirrors a decrement of viable fungal cells by the direct con-
tact with MoWs, as assessed by bioluminescence sensitivity.
Pretreatment of the fungus with the MoWs alters epithelial cell secretory response to some
extent. In particular, IL-1α and IL-1β, secreted at high levels upon infection, significantly
decrease in epithelia infected with MoWs-pretreated Candida. To our opinion, this result sug-
gests that MoWs may play a relevant role in modulating Candida virulence. Epithelia, which
cover all the mucosal surfaces of human body, must be able to discriminate between the inva-
sive (pathogenic) and the commensal (harmless) forms of Candida, in order to prevent fungal
invasion [12]. The reduced secretion of the pro-inflammatory cytokines IL-1α and IL-1β when
Candida is pre-exposed to MoWs, indicates that under these conditions epithelial cells do not
sense Candida as a threat, suggesting that fungal virulence potential has been attenuated. Dif-
ferently, significant production of IL-1α and IL-1β occurs when epithelial cells are infected
with PBS-treated fungi (control group); thus, under these conditions, the fungus retains its
pathogenic potential, maintaining its capacity to adhere and to invade host tissues, as it may
often be perceived at the mucosal level.
By a previously established in vitro model, which makes use of the murine microglial cell
line BV2, as a prototype of tissue macrophages endowed with potent phagocytic activity and
intra-cellular killing against Candida [34,41], here we show that the exposure to MoWs
affects Candida susceptibility to such host-mediated first line defense. We show that, irre-
spective of the PBS or MoWs pretreatment, approximately 50% of the BV2 cells are able to
ingest Candida cells, with a phagocytosis percentage and a phagocytosis index that remain
substantially unchanged among groups. These data imply that MoWs do not alter the way
phagocytes perceive the fungus in their surrounding environment, since their phagocytic
activity remains almost unaffected. Differently, assessment of acidic phagolysosomes per-
centage highlights significant differences, depending upon the MoWs used. When Candida
cells are pretreated with MoWs 1 and 4, the acidic phagolysosomes percentages remain sub-
stantially unchanged and similar to those of PBS-pretreated Candida. Morphological obser-
vations clearly show that microglial cells that have ingested Candida pretreated with MoWs
2, 3, 5 and 7 return acidic phagolysosomes percentages significantly higher than those
observed with Candida pretreated with PBS. Interestingly, this phenomenon is to be ascribed
to the inhibition of fungal dimorphic transition. Indeed, fungi treated with such MoWs
remain in a yeast form and they are rapidly associated with acidic phagolysosomes It is
worth noting that the MoWs capable to impair Candida dimorphic transition and, in turn,
intracellular compartment acidification contain either CHX or essential oils in their
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formulation. These results are in line with the literature reporting that alcohol- and/or CHX-
containing MoWs have the highest antibacterial effects in vitro [43,44] and in the oral cavity
[45]. Initial studies employing Candida spp. [46] have shown that CHX-containing MoWs
are also effective against fungal cells, both in planktonic [47] and sessile forms [16,48]. Fur-
thermore, in agreement with our present data, recent reports have shown that also MoWs
containing essential oils have antifungal effects on several species of Candida [49]. Differ-
ently, the pretreatment with MoWs 1 and 4 does not impair Candida dimorphic transition
and the fungus maintains its capacity to form hyphae as well as control group, irrespective of
its intracellular and extracellular localization. Consequently, once phagocytosed, Candida
can avoid phagolysosome acidification and in turn intracellular killing, probably via distur-
bance of the vacuolar membranes by the growing hyphae. We favour the idea that the pres-
ence of an anti-discoloration system (ADS) in the formulation of MoW 1 (which
nevertheless contains 0.20% CHX, as well as MoWs 2 and 3), may partially interfere with
CHX-mediated anti-fungal effects. Interestingly, upon incubation with MoW 1, only Can-
dida capacity to form biofilm [16] and its susceptibility to phagocytes remain unchanged,
while other virulence traits, such as adhesion and elicitation of proinflammatory cytokines,
are affected. Once again, the results of fungal cell viability are in line with these data.
On selected experiments, MoWs containing either CPC or Triclosan have been used. CPC-
containing MoWs have been reported to be more effective on the planktonic, rather than the
sessile form of C. albicans [48]. Here, we strengthen and expand such data, by showing that
only CPC-containing MoW 8 indeed impairs adhesion of the yeast form of C. albicans to both
biotic and abiotic surfaces.
As for the streptococci employed in the present study, we have chosen several species acting
as early colonizers in multispecies microbial biofilm formation on dental surface [20]. All
these species may play a role, albeit an indirect one, in the onset of several pathologies affecting
the oral cavity, including caries. When using CHX-containing MoWs, a significant
impairment in bacterial biofilm production has been observed for 4 out of 6 species investi-
gated, i.e., S. salivarius, S. vestibularis, S. parasanguinis and E. faecalis. A slightly lower effect
has been observed upon treatment with MoW 5. Based on the fact that CHX-containing
MoWs (1, 2, 3 and 7) and, although to a lesser extent, the essential oils-containing MoW 5
impair biofilm formation by the so-called “pro-cariogenic” bacterial species [50–52], we specu-
late that such MoWs may indirectly provide protection against carious lesions onset. CPC,
which is included in the formulation of several toothpastes and MoWs, is known to have anti-
plaque and anti-gingivitis effects [53]. In our hands, CPC-containing MoW 8 happens to
impair biofilm formation by S. salivarius even more effectively than CHX-containing MoWs.
In contrast, Triclosan-containing MoW 9 does not seem to have any effect, in line with previ-
ous data reporting lack of antimicrobial effects and the induction of bacterial resistance mech-
anisms by Triclosan-containing cosmetic products [54]. Differently, the treatment of S.
sanguinis and S. mitis/oralis isolates with the MoWs does not affect their biofilm formation.
Noteworthy, S. sanguinis acts as a natural competitor of S. mutans, by establishing spatial and
temporal antagonistic relationships with several mechanisms [55]. In addition, S. sanguinis, S.
mitis and S. oralis produce small molecules with antibiotic-like activity, capable to inhibit the
growth of other potentially pathogenic microorganisms, such as C. albicans and Staphylococcus
aureus [20,56]. As a direct evidence of their beneficial role, S. sanguinis, S. mitis and S. oralis
have been found to be predominant on oral mucosae of healthy subjects [57]. Taking together
all these data, we may speculate that the MoWs here employed are effective in contrasting car-
ies onset since not only they reduce the colonization of bacterial species that (albeit indirectly)
have a potential pathogenic effect, but also they do not damage bacterial species which are
competitors of the cariogenic S. mutans.
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Finally, in order to assess if MoWs may impact on Candida-streptococci interplay, we have
co-infected TR146 oral epithelial cells with untreated C. albicans and MoWs-treated S. salivar-
ius. In particular, S. salivarius isolate number 12 has been chosen, being its biofilm formation
the most impaired by MoWs. Our results show that once exposed to MoW 1 and MoW 5, S.
salivarius partially inhibits Candida biofilm formation. In particular, early biofilm (24 hours
from infection) but not mature Candida biofilm (48 hours from infection) is slightly affected,
the latter irrespective of the MoW employed. By these data, we conclude that S. salivarius
treated with MoWs 1 and 5 delays Candida biofilm formation, but it fails to stop it completely.
MoWs affect several virulence traits of the oral microbiota, acting on both fungal and bacte-
rial cells. According to our past [16] and present results, CHX- and essential oils-containing
MoWs exhibit the most powerful anti-Candida effects impairing biofilm formation, adhesion,
elicitation of proinflammatory responses and enhancing intracellular killing via acidic phago-
lysosomes. Also, viridans streptococci capacity to form biofilm is deeply affected. Notwith-
standing its effectiveness, notoriously CHX has several side-effects (staining of teeth, loss of
taste, numb feeling [58]) that have to be considered when employing MoWs containing this
molecule. On the other side, CHX-free MoWs, which include fluorine-containing molecules
in their formulation, provide some help in the process of enamel remineralization (and conse-
quently in caries prevention) [59], but they may not ensure a direct protection against patho-
genic microorganisms. CPC-containing MoW seems a promising alternative to CHX-
containing MoWs, even though more in-depth comparative studies are required to confirm
these data. Finally, the lack of effect of Triclosan-containing MoW 9 does not warrant further
studies. In addition, Triclosan has recently been banned from some cosmetic products by the
FDA in the USA, because of the concerns on its side effects on human health [54].
In conclusion, because of the complexity of the oral environment and of the possible side
effects of the active molecules of their formulations, special attention should be used when
choosing MoWs for prevention and/or treatment of oral pathologies, also according to the eti-
ological agent likely involved.
Supporting information
S1 Table. Details of the mouthwashes employed in the study. Commercial names and com-
position (with indication of the main components) are provided.
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